FindTrial
Sign In

The predictive value for perioperative coagulation monitoring (Sonoclot) to assess the risk of thrombosis in pediatric living donor liver transplantation

The predictive value for perioperative coagulation monitoring (Sonoclot) to assess the risk of thrombosis in pediatric living donor liver transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026125
Enrollment
Unknown
Registered
2019-09-22
Start date
2019-09-20
Completion date
Unknown
Last updated
2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary Atresia

Interventions

1:ACT>228.5s
2:ACT<228.5s

Sponsors

Tianjin First Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 5 Years

Inclusion criteria

Inclusion criteria: 1. ASA grade II~III; 2. NYHA grade I~II; 3. Diagnosis of children with biliary atresia, undergoing ralated liver transplantaion.

Exclusion criteria

Exclusion criteria: 1. Re-transplantation; 2. Combined with heart, lung, kidney, and brain failure before operarion; 3. Combined with congenital diseases such as congenital heart disease before operarion; 4. Application of heparin drugs; 5. Participants with severe arrhythmia, major bleeding and other complications during surgery.

Design outcomes

Primary

MeasureTime frame
Incidence of early thrombosis;—

Secondary

MeasureTime frame
Volume of blood and FFP transfusion;—

Countries

China

Contacts

Public ContactWenli Yu

Tianjin First Center Hospital

yzxwenliyu@163.com+86 139 2009 8326

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026